FDA Approves Esketamine Nasal Spray as Standalone Treatment for Depression

FDA Approves Esketamine Nasal Spray as Standalone Treatment for Depression

FDA Approves Spravato Nasal Spray‍ as Standalone Treatment for Major ⁢Depressive Disorder In a groundbreaking move, the U.S. food and Drug Governance (FDA) has approved a supplemental‌ new drug request for Spravato (esketamine) nasal spray, allowing it to be used as ⁤a standalone treatment for adults with major depressive⁢ disorder (MDD) who have not responded … Read more

Neumora Stock Crashes: Depression Drug Trial Fails

Neumora Stock Crashes: Depression Drug Trial Fails

neumora Stock Plunges After Depression Drug ‍Trial Fails Table of Contents neumora Stock Plunges After Depression Drug ‍Trial Fails Neumora Setback: What Does Failed Trial Mean for⁤ Depression Treatment? Navigating the Disappointment Understanding the Study’s Limitations Implications for Future Research Neumora’s Path Forward Hope for Patients Shares⁣ of​ Neumora therapeutics ⁢Inc.experienced a record-breaking drop after … Read more